Therapeutics

Tools

Back to the Top
Search By Attributes

Search Results

Name Synonyms FDA Status Company Target Type Therapy Type Approved
For
AADvac1 Axon peptide 108 conjugated to KLH Alzheimer's Disease (Phase 2), Progressive Nonfluent Aphasia (Phase 1) Axon Neuroscience SE Tau Immunotherapy (active)
ABvac40 Alzheimer's Disease (Phase 2) Araclon Biotech Amyloid-Related Immunotherapy (active)
ACI-24 ACI-24.060,
Pal1-15 acetate salt
Alzheimer's Disease (Phase 2), Down's Syndrome (Phase 2) AC Immune SA Amyloid-Related Immunotherapy (active)
UB-311 Alzheimer's Disease (Phase 2) United Neuroscience, Vaxxinity Amyloid-Related Immunotherapy (active)